The content on this site is intended for healthcare professionals only
CAR T therapy is compared to auto transplants, highlighting its effectiveness in paediatric cases over decades. The need for alternatives is stressed due to poor outcomes in relapsed patients. Social interventions play a crucial role in increasing treatment cases. The development of CAR T in India shows promising progress, with a focus on safety and efficacy. Guidelines for treatment choices emphasise local innovation while cautioning against first-line use due to potential risks.
Made to measure: Choosing the optimal regimen in transplant-eligible NDMM
Advancements in paediatric Acute lymphoblastic leukemia management
ESMO 2024: Best practice in HRRm testing in patients with metastatic prostate cancer
Multiple myeloma In Rwanda: The need for further research
Bone disease evaluation of newly diagnosed MM with combined use of 18F-FDG PET/CT and whole-body diffusion weighted MRI
Treatment of multiple myeloma in Turkey
ELCC 2024: Latest in EGFR mutant lung cancer; exon 20 mutation focus
Multiple myeloma in a resource constrained setting
Haemato-oncological Cancers
